BusinessExosome Diagnostics and Chesapeake Urology Partner to Evaluate Clinical Value of ExoDx® Prostate(IntelliScore) in First Study Under Novel Evidence Development CollaborationBy Nasdaq OMXSep 19, 2017, 11:31 AM UTC